1 September 2024
Marketing Clearance for VivaGel® condom in New Zealand
Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced the completion of the regulatory requirements to allow for marketing of the VivaGel® condom in New Zealand under the brand Lifestyles® Dual Protect™.
Starpharma’s commercial partner, Ansell, along with their New Zealand distributor, EBOS Group, plan to launch the Lifestyles® Dual Protect™ condom in the New Year having obtained market clearance for New Zealand.
Dual Protect™ with VivaGel® is the world’s first antiviral condom.
Starpharma CEO, Dr Jackie Fairley, said, “We are very pleased to announce this next approval of the VivaGel® condom for marketing, and look forward to further regulatory acceptances and launches of the product in other regions in the future.”
The New Zealand label for Dual Protect™ will carry the following information:
- Dual Protect™ incorporates a lubricant which contains VivaGel®
- VivaGel® has been shown in laboratory studies to inactivate up to 99.9% of HIV, Herpes and HPV which are common viruses that cause STIs.
Lifestyles® Dual Protect™ condoms are available in Woolworths stores across Australia and regulatory processes are underway in other markets.
Download ASX Announcement: Marketing Clearance for VivaGel® condom in New Zealand ( pdf file, 110kb)